Literature DB >> 24763406

Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.

Mustafa Gür1, Caner Türkoğlu2, Abdullah Taşkın3, Hakan Uçar2, Abdurrezzak Börekçi4, Taner Seker2, Mehmet Yavuz Gözükara5, Onur Kaypaklı2, Selahattin Akyol2, Sahbettin Selek3, Durmuş Yıldıray Sahin2, Zafer Elbasan2, Murat Caylı2.   

Abstract

BACKGROUND: Reperfusion and ischemic injuries are pathogenetic mechanisms of no-reflow. Oxidative stress plays a critical role during ischemia as well as during the reperfusion phase following ST elevation myocardial infarction (STEMI). We sought to investigate the relationship between no-reflow with paraoxonase-1 (PON-1) activity and oxidative stress markers (total antioxidant capacity (TAC), total oxidant status (TOS), oxidative stress index (OSI), lipid hydro-peroxide (LOOH)) in patients with anterior STEMI undergoing primary percutaneous coronary intervention (PCI).
METHODS: In this study, 319 consecutive anterior STEMI patients undergoing primary PCI were prospectively included (mean age 56.5 ± 12.5 years). The patients were divided into two groups as normal flow (n = 231) and no-reflow (n = 88) groups. Serum PON-1 activity was measured spectrophotometrically. TAC and TOS levels were determined by using an automated measurement method. LOOH levels were measured by ferrous oxidation with xylenol orange assay.
RESULTS: PON-1 activity and TAC levels were significantly lower and TOS, OSI and LOOH levels were significantly higher in patients with no-reflow compared to normal flow group (p < 0.05, for all). On multivariate logistic regression analysis, PON-1 activity (β = 0.976, 95% CI = 0.962-0.990, p = 0.001) and OSI (β = 1.094, 95% CI = 1.042-1.148, p < 0.001) as well as diabetes, infarction time, thrombus score and initial SYNTAX score were independently associated with no-reflow.
CONCLUSION: In patients with no-reflow compared with normal flow, oxidants are increased, while serum PON-1 activity and antioxidants are decreased. This result shows that increased oxidative stress has a role in the pathogenesis of no-reflow.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidant; Myocardial infarction; No-reflow; Oxidative stress; Paraoxonase

Mesh:

Substances:

Year:  2014        PMID: 24763406     DOI: 10.1016/j.atherosclerosis.2014.03.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Predictors of Impaired Reperfusion after Percutaneous Coronary Intervention in Patients with In-Hospital Acute Stent Thrombosis: A Retrospective Analyses of 5 Years of Data.

Authors:  Burak Açar; Orhan Maden; Kevser Gülcihan Balci; Sefa Ünal; Mustafa Mücahit Balci; Esra İpek Gücük; Meryem Kara; Hatice Selcuk; Mehmet Timur Selcuk
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

2.  Nesfatin-1 Levels Predict Angiographic No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Serkan Sivri; Erdoğan Sökmen; Mustafa Çelik; Kenan Güçlü
Journal:  Acta Cardiol Sin       Date:  2020-07       Impact factor: 2.672

3.  Paraoxonase and arylesterase activities in dipper and non-dipper prehypertensive subjects.

Authors:  Murat Yuksel; Abdulkadir Yildiz; Ebru Tekbas; Ercan Gunduz; Aysun Ekinci; Mehmet Zihni Bilik; Necdet Ozaydogdu; Zuhal Atilgan
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Therapeutic Hypothermia Reduces Oxidative Damage and Alters Antioxidant Defenses after Cardiac Arrest.

Authors:  Fernanda S Hackenhaar; Tássia M Medeiros; Fernanda M Heemann; Camile S Behling; Jordana S Putti; Camila D Mahl; Cleber Verona; Ana Carolina A da Silva; Maria C Guerra; Carlos A S Gonçalves; Vanessa M Oliveira; Diego F M Riveiro; Silvia R R Vieira; Mara S Benfato
Journal:  Oxid Med Cell Longev       Date:  2017-05-01       Impact factor: 6.543

5.  Association between oxidative stress index and post-CPR early mortality in cardiac arrest patients: A prospective observational study.

Authors:  Hasan Yücel; Kenan Ahmet Türkdoğan; Ali Zorlu; Hüseyin Aydın; Recep Kurt; Mehmet Birhan Yılmaz
Journal:  Anatol J Cardiol       Date:  2014-10-15       Impact factor: 1.596

6.  Predicting value of white cell count and total bilirubin on clinical outcomes in patients with ST-elevation myocardial infarction following percutaneous coronary intervention: a cohort study.

Authors:  Munire Tuxun; Qian Zhao; Yang Xiang; Fen Liu; Chun-Fang Shan; Xin-Rong Zhou; Ning Song; Ajiguli Waisiding; Xue-He Zhang; Gulandanmu Aihemaiti; Yi-Ning Yang; Xiao-Mei Li
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

7.  MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Xin-Tao Zhang; Zhao-Rong Lin; Lin Zhang; Zi-Wen Zhao; Liang-Long Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-03-18       Impact factor: 2.298

8.  Serum Paraoxonase, Arylesterase, and Glutathione-S-Transferase Activities and Oxidative Stress Levels in Patients with Mushroom Poisoning.

Authors:  Sevki Hakan Eren; Ilhan Korkmaz; Fatma Mutlu Kukul Guven; Yusuf Kenan Tekin; Levent Ozdemir
Journal:  Clinics (Sao Paulo)       Date:  2018-07-10       Impact factor: 2.365

9.  Relationship between Paraoxonase-1 and Arylesterase Enzyme Activities and SYNTAX I and II Scores in Patients with ST-Elevation Myocardial Infarction.

Authors:  Erdoğan Sökmen; Mustafa Çelik; Serkan Sivri; Kenan Güçlü
Journal:  J Tehran Heart Cent       Date:  2019-10

10.  Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention.

Authors:  Qinyao Zhang; Meirong Hu; Shumei Ma
Journal:  J Atheroscler Thromb       Date:  2021-02-05       Impact factor: 4.928

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.